Walker Alejandro R, Shields Robert C
Department of Oral Biology, University of Florida, Gainesville, FL, United States.
Department of Biological Sciences, Arkansas State University, Jonesboro, AR, United States.
Front Genet. 2022 Sep 15;13:997341. doi: 10.3389/fgene.2022.997341. eCollection 2022.
CRISPR-Cas is a bacterial immune system that restricts the acquisition of mobile DNA elements. These systems provide immunity against foreign DNA by encoding CRISPR spacers that help target DNA if it re-enters the cell. In this way, CRISPR spacers are a type of molecular tape recorder of foreign DNA encountered by the host microorganism. Here, we extracted ∼8,000 CRISPR spacers from a collection of over three hundred genomes. Phage DNA is a major target of spacers. S. mutans strains have also generated immunity against mobile DNA elements such as plasmids and integrative and conjugative elements. There may also be considerable immunity generated against bacterial DNA, although the relative contribution of self-targeting versus bona fide intra- or inter-species targeting needs to be investigated further. While there was clear evidence that these systems have acquired immunity against foreign DNA, there appeared to be minimal impact on horizontal gene transfer (HGT) constraints on a species-level. There was little or no impact on genome size, GC content and 'openness' of the pangenome when comparing between strains with low or high CRISPR spacer loads. In summary, while there is evidence of CRISPR spacer acquisition against self and foreign DNA, CRISPR-Cas does not act as a barrier on the expansion of the accessory genome.
CRISPR-Cas是一种细菌免疫系统,可限制移动DNA元件的获取。这些系统通过编码CRISPR间隔序列来提供对外源DNA的免疫,这些间隔序列有助于在DNA重新进入细胞时靶向DNA。通过这种方式,CRISPR间隔序列是宿主微生物遇到的外源DNA的一种分子录音机。在这里,我们从三百多个基因组的集合中提取了约8000个CRISPR间隔序列。噬菌体DNA是间隔序列的主要靶标。变形链球菌菌株也对质粒、整合性接合元件等移动DNA元件产生了免疫。虽然自我靶向与真正的种内或种间靶向的相对贡献需要进一步研究,但对细菌DNA也可能产生相当大的免疫。虽然有明确证据表明这些系统已获得对外源DNA的免疫,但在物种水平上对水平基因转移(HGT)限制的影响似乎最小。在比较CRISPR间隔序列负载低或高的菌株时,对基因组大小、GC含量和泛基因组的“开放性”几乎没有影响。总之,虽然有证据表明CRISPR间隔序列可针对自身和外源DNA进行获取,但CRISPR-Cas并不构成辅助基因组扩展的障碍。